Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-076459
Filing Date
2023-06-29
Accepted
2023-06-29 18:42:26
Documents
1
Period of Report
2023-06-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320271-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2320271-4_4seq1.xml 4 5937
  Complete submission text file 0001104659-23-076459.txt   7328
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYENOVIA, INC 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address
Palanki Ram (Reporting) CIK: 0001937411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 231058851